Developer docs
API playgroundTry for free, no card

Search company profiles

Bloodbuy

Full company profile

uuid00056ih

Namestring
Bloodbuy
Legal namestring
BloodSolutions, LLC
Websiteurl
bloodbuy.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Bloodbuy (legally BloodSolutions, LLC) is a Dallas-based, privately held healthcare technology company founded in 2013 that operates a digital marketplace platform connecting blood collection centers with hospitals and integrated healthcare delivery networks. The platform addresses a fragmented and regionally siloed blood supply chain by enabling real-time matching between supply (38 industry-leading blood collectors) and demand (450+ hospitals organized into 160+ delivery networks), with operations spanning the United States, Europe, and Asia. The company is also expanding into the life sciences sector to serve companies requiring blood products for research or manufacturing. The platform is delivered through a website-based exchange with self-serve onboarding and direct sales, and the company is led by founder and CEO Christopher Godfrey alongside a small multidisciplinary team spanning technology, healthcare, science, design, engineering, and operations.

The underlying technology is a web-based marketplace built on Python, Django, and JavaScript, deployed on AWS and Heroku, and protected by three granted US patents (Nos. 10,636,521; 11,551,809; and 11,948,679). The company maintains a bi-weekly agile feature release cadence (current platform version v4.61.4) and emphasizes cross-network interoperability as its primary technical differentiator. Distribution is supported by an earned-media presence across Wired, Harvard Business Review, TechCrunch, NPR, Bloomberg, Becker's, FierceHealthcare, and other industry publications, supplemented by a content marketing blog (Hemoblogin) covering blood industry trends.

Bloodbuy operates under a marketplace commission revenue model with transaction-based / take-rate pricing governed by a non-public Exchange Participation Agreement. Its go-to-market motion is sales-led, using "Request a Demo" and "Let's Connect" CTAs to engage enterprise hospital networks and blood centers. The company is financially backed and strategically aligned with three industry-leading healthcare organizations: Premier, Inc. (NASDAQ: PINC), Grifols, S.A. (NASDAQ: GRFS), and Providence St. Joseph Health. Its only disclosed funding round was a $3.75 million raise in February 2016 led by Premier Inc and St. Joseph's Health System. Revenue, ownership structure beyond the named backers, and detailed financial metrics are not publicly disclosed.

Short descriptiontext

Bloodbuy operates a digital marketplace connecting 38 blood collectors with 450+ hospitals across 160+ integrated healthcare delivery networks in the US, Europe, and Asia, earning marketplace commissions on blood product transactions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDallas, United States
HQ citystring
Dallas
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
blood product exchange, healthcare supply chain, blood distribution platform, medical marketplace software, hospital blood sourcing
Industry3 codes
1Plasma-Derived & Blood Products Distributors
CodeHLAIAJAJPrimaryYes
2Blood Bank/Transfusion Medicine LIS
CodeHLACAMAEPrimaryNo
3Transfusion Medicine & Immunohematology (Blood Bank)
CodeHLAFAMAGPrimaryNo
NAICS code2 codes
  • Blood and Organ Banks621991
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services518
SIC code1 code
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Healthcare Blood Supply Chain Marketplace
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Platform Transaction/Exchange Fees
TypeMarketplace Commission
Description

Bloodbuy operates a digital exchange/marketplace connecting blood product suppliers with healthcare providers. The platform facilitates transactions between blood centers and hospitals, likely earning transaction fees or a take rate on exchanges conducted through the platform.

bloodbuy.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Enterprise B2B platform - quote-based pricing
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Terms and conditions governed by Exchange Participation Agreement - not publicly disclosed

exchange.bloodbuy.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Hemoblogin
Description

Bloodbuy's blog covering blood industry news, trends, and insights

bloodbuy.com
Core offering1 text field

Bloodbuy operates a digital marketplace platform that connects blood centers and blood collectors with hospitals and integrated healthcare delivery networks to facilitate the efficient distribution of lifesaving blood products. The platform serves over 160 healthcare delivery networks, 450+ hospitals, and 38 industry-leading blood collectors across the United States, Europe, and Asia, monetizing transactions conducted through the exchange.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over 160 integrated healthcare delivery networks served
+3 more records
Product overview1 text field

Bloodbuy offers a single unified digital marketplace platform that connects blood centers with hospitals across the United States. The platform enables healthcare delivery networks to source lifesaving blood products directly from industry-leading blood collectors, facilitating efficient distribution across a network of over 450 hospitals and 38 blood centers.

Product and service1 record
1Bloodbuy Exchange Platform
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Cerus Corporation
TypeOthers
Description

Provides blood safety and pathogen-reduction technology for transfusion medicine, an adjacent technology player in the same blood supply ecosystem Bloodbuy serves.

2Blood Centers of America (BCA)
TypeDirect peer
Description

A cooperative aggregating blood-product purchasing and distribution across member blood centers, directly overlapping Bloodbuy's role in optimizing blood supply matching between centers and hospitals.

3Haemonetics
TypeBroad incumbent
Description

Global blood management technology company offering blood collection, processing, and software (e.g., SafeTrace); overlaps with Bloodbuy's transfusion-medicine and blood supply-chain technology focus.

4WellSky
TypeEmerging player
Description

Health IT vendor providing blood bank and transfusion management software (SafeTrace Tx, HemaTerra), overlapping Bloodbuy's digital blood-bank informatics and inventory management use case.

5Vitalant
TypeOthers
Description

One of the largest US nonprofit blood collection and distribution organizations; a supply-side ecosystem participant whose distribution needs Bloodbuy's platform addresses.

6American Red Cross Blood Services
TypeOthers
Description

Major national blood collector and distributor; an ecosystem incumbent in the blood supply chain that Bloodbuy's marketplace connects to hospital demand.

7OneBlood
TypeRegional player
Description

Regional blood center serving the southeastern US with collection and distribution operations, comparable as a blood supply participant but geographically focused rather than a national exchange.

8Grifols
TypeOthers
Description

Global plasma-derived medicines and blood products manufacturer (and a Bloodbuy backer); operates in the same blood/plasma value chain as a supplier and ecosystem participant.

9Cohealo
TypeEmerging player
Description

Healthcare asset-sharing marketplace connecting hospitals to optimize resource utilization; comparable in its marketplace/network model applied to hospital supply chains.

10Cardinal Health
TypeBroad incumbent
Description

Large medical products distributor supplying hospitals; overlaps as a broad healthcare supply-chain incumbent, though not specialized in blood-product exchange.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bloodbuy

Healthcare Blood Supply Chain Marketplacebloodbuy.com

Bloodbuy operates a digital marketplace connecting 38 blood collectors with 450+ hospitals across 160+ integrated healthcare delivery networks in the US, Europe, and Asia, earning marketplace commissions on blood product transactions.

What Bloodbuy does

Bloodbuy (legally BloodSolutions, LLC) is a Dallas-based, privately held healthcare technology company founded in 2013 that operates a digital marketplace platform connecting blood collection centers with hospitals and integrated healthcare delivery networks. The platform addresses a fragmented and regionally siloed blood supply chain by enabling real-time matching between supply (38 industry-leading blood collectors) and demand (450+ hospitals organized into 160+ delivery networks), with operations spanning the United States, Europe, and Asia. The company is also expanding into the life sciences sector to serve companies requiring blood products for research or manufacturing. The platform is delivered through a website-based exchange with self-serve onboarding and direct sales, and the company is led by founder and CEO Christopher Godfrey alongside a small multidisciplinary team spanning technology, healthcare, science, design, engineering, and operations.

The underlying technology is a web-based marketplace built on Python, Django, and JavaScript, deployed on AWS and Heroku, and protected by three granted US patents (Nos. 10,636,521; 11,551,809; and 11,948,679). The company maintains a bi-weekly agile feature release cadence (current platform version v4.61.4) and emphasizes cross-network interoperability as its primary technical differentiator. Distribution is supported by an earned-media presence across Wired, Harvard Business Review, TechCrunch, NPR, Bloomberg, Becker's, FierceHealthcare, and other industry publications, supplemented by a content marketing blog (Hemoblogin) covering blood industry trends.

Bloodbuy operates under a marketplace commission revenue model with transaction-based / take-rate pricing governed by a non-public Exchange Participation Agreement. Its go-to-market motion is sales-led, using "Request a Demo" and "Let's Connect" CTAs to engage enterprise hospital networks and blood centers. The company is financially backed and strategically aligned with three industry-leading healthcare organizations: Premier, Inc. (NASDAQ: PINC), Grifols, S.A. (NASDAQ: GRFS), and Providence St. Joseph Health. Its only disclosed funding round was a $3.75 million raise in February 2016 led by Premier Inc and St. Joseph's Health System. Revenue, ownership structure beyond the named backers, and detailed financial metrics are not publicly disclosed.

Bloodbuy firmographics

Firmographics
Name
Bloodbuy
Legal name
BloodSolutions, LLC
Website
https://bloodbuy.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
Bloodbuy operates a digital marketplace connecting 38 blood collectors with 450+ hospitals across 160+ integrated healthcare delivery networks in the US, Europe, and Asia, earning marketplace commissions on blood product transactions.
Ownership category
akta.pro rank

Bloodbuy industry classification

Industry
Product category
Healthcare Blood Supply Chain Marketplace
NAICS
Blood and Organ Banks (621991), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)
SIC
Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro primary industry
Plasma-Derived & Blood Products Distributors (HLAIAJAJ)
akta.pro secondary industries
Blood Bank/Transfusion Medicine LIS (HLACAMAE), Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG)

Keywords

  • Blood product exchange
  • Healthcare supply chain
  • Blood distribution platform
  • Medical marketplace software
  • Hospital blood sourcing

Where Bloodbuy is headquartered

Location

Headquarters

HQ city
Dallas
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Bloodbuy business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Platform Transaction/Exchange Fees: Bloodbuy operates a digital exchange/marketplace connecting blood product suppliers with healthcare providers. The platform facilitates transactions between blood centers and hospitals, likely earning transaction fees or a take rate on exchanges conducted through the platform.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goEnterprise B2B platform - quote-based pricing

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Bloodbuy product offering

Product offering

Core offering

Bloodbuy operates a digital marketplace platform that connects blood centers and blood collectors with hospitals and integrated healthcare delivery networks to facilitate the efficient distribution of lifesaving blood products. The platform serves over 160 healthcare delivery networks, 450+ hospitals, and 38 industry-leading blood collectors across the United States, Europe, and Asia, monetizing transactions conducted through the exchange.

Product overview

Bloodbuy offers a single unified digital marketplace platform that connects blood centers with hospitals across the United States. The platform enables healthcare delivery networks to source lifesaving blood products directly from industry-leading blood collectors, facilitating efficient distribution across a network of over 450 hospitals and 38 blood centers.

Differentiator

Problem solved

Functional benefit

Brands

  • Hemoblogin: Bloodbuy's blog covering blood industry news, trends, and insights

Products and services

  • Bloodbuy Exchange Platform

Quantifiable outcome

  • Over 160 integrated healthcare delivery networks served
  • +3 more outcomes

Companies that use Bloodbuy

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Bloodbuy technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Bloodbuy partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Bloodbuy competitors and assessment

Company assessment

Others

  • Cerus Corporation: Provides blood safety and pathogen-reduction technology for transfusion medicine, an adjacent technology player in the same blood supply ecosystem Bloodbuy serves.
  • Vitalant: One of the largest US nonprofit blood collection and distribution organizations; a supply-side ecosystem participant whose distribution needs Bloodbuy's platform addresses.
  • American Red Cross Blood Services: Major national blood collector and distributor; an ecosystem incumbent in the blood supply chain that Bloodbuy's marketplace connects to hospital demand.
  • Grifols: Global plasma-derived medicines and blood products manufacturer (and a Bloodbuy backer); operates in the same blood/plasma value chain as a supplier and ecosystem participant.

Direct peers

  • Blood Centers of America (BCA): A cooperative aggregating blood-product purchasing and distribution across member blood centers, directly overlapping Bloodbuy's role in optimizing blood supply matching between centers and hospitals.

Broad incumbents

  • Haemonetics: Global blood management technology company offering blood collection, processing, and software (e.g., SafeTrace); overlaps with Bloodbuy's transfusion-medicine and blood supply-chain technology focus.
  • Cardinal Health: Large medical products distributor supplying hospitals; overlaps as a broad healthcare supply-chain incumbent, though not specialized in blood-product exchange.

Emerging players

  • WellSky: Health IT vendor providing blood bank and transfusion management software (SafeTrace Tx, HemaTerra), overlapping Bloodbuy's digital blood-bank informatics and inventory management use case.
  • Cohealo: Healthcare asset-sharing marketplace connecting hospitals to optimize resource utilization; comparable in its marketplace/network model applied to hospital supply chains.

Regional players

  • OneBlood: Regional blood center serving the southeastern US with collection and distribution operations, comparable as a blood supply participant but geographically focused rather than a national exchange.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Bloodbuy social profiles

Digital presence

Bloodbuy financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bloodbuy leadership team

Management profile

Number of profiles

Profiles2 records

Bloodbuy funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bloodbuy M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bloodbuy

What does Bloodbuy do?

Bloodbuy operates a digital marketplace platform that connects blood centers and blood collectors with hospitals and integrated healthcare delivery networks to facilitate the efficient distribution of lifesaving blood products. The platform serves over 160 healthcare delivery networks, 450+ hospitals, and 38 industry-leading blood collectors across the United States, Europe, and Asia, monetizing transactions conducted through the exchange.

Is Bloodbuy a public or private company?

Bloodbuy is a private company. It is classified as venture growth investor backed and is currently operating.

When was Bloodbuy founded?

Bloodbuy was founded in 2013. It employs 11 to 50 people.

Where is Bloodbuy based?

Bloodbuy is headquartered in Dallas, United States, in the North America region.

How does Bloodbuy make money?

One revenue line is on record: platform Transaction/Exchange Fees.

Who are Bloodbuy's main competitors?

Others on record are Cerus Corporation, Vitalant, American Red Cross Blood Services and Grifols. Blood Centers of America (BCA) is listed as a direct peer. Broad incumbents are Haemonetics and Cardinal Health. Emerging players are WellSky and Cohealo. OneBlood is listed as a regional player.

Does Bloodbuy have an API?

No public API is recorded for Bloodbuy.

What industry is Bloodbuy in?

Bloodbuy's product category is Healthcare Blood Supply Chain Marketplace. Its primary akta.pro industry code is HLAIAJAJ, Plasma-Derived & Blood Products Distributors, with a secondary code of HLACAMAE, Blood Bank/Transfusion Medicine LIS. Its NAICS code is 621991 and its SIC code is 5047.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireGrifols acquires 10% stake in Bloodbuy, cloud-based marketplace for blood productsGrifols announced it has acquired a 10% stake in Bloodbuy (BloodSolutions, LLC), a cloud-based marketplace facilitating the buying and selling of blood components across the United States. As part of the investment, Grifols will obtain a seat on Bloodbuy's Board of Directors, enabling the company to contribute to Bloodbuy's growth and analyze the blood-component-product marketplace for potential further investments in digital healthcare. The announcement comes as COVID-19 has created supply and demand challenges for blood products, with the platform helping to redistribute available blood products and connect stakeholders including COVID-19 convalescent plasma.TechCrunchPlaying catch-up in hospital innovationThe author argues that while billions in funding target cancer, hospitals remain inefficient, citing over 7 million preventable adverse drug events causing 7,000 annual deaths and $21 billion in avoidable costs. He urges entrepreneurs to build cloud-based hospital tools, citing PipelineRx's telepharmacy and Bloodbuy's blood marketplace.PR NewswireBloodbuy Wins First Harvard Business School-Harvard Medical School Health Acceleration ChallengeDallas-based company Bloodbuy was named the winner of the first Harvard Business School-Harvard Medical School Health Acceleration Challenge, receiving an additional $50,000 prize. The award recognizes Bloodbuy's technology platform that connects hospitals and blood centers to improve the efficiency of blood product distribution. The competition involved 478 applicants and selected Bloodbuy from four finalists based on its ability to address supply-demand imbalances in healthcare.FinSMEsBloodbuy Raises $3.75M in FundingBloodbuy, a Dallas-based healthcare IT company, raised $3.75M from Premier Supply Chain Improvement and St. Joseph Health. The funds will support expansion of its hospital and blood center network, team growth, and new technology offerings. The company also announced a strategic relationship with Premier to offer its technology to Premier's membership.